Literature DB >> 7942759

Parity, contraception, infertility, and the risk of epithelial ovarian cancer.

H A Risch1, L D Marrett, G R Howe.   

Abstract

A case-control study of reproductive factors and cancer of the ovary was conducted during 1989-1992 in metropolitan Toronto and nearby areas of Southern Ontario, Canada. In total, 450 women aged 35-79 years with histologically verified new primary epithelial ovarian cancers were interviewed concerning their reproductive histories. Over the same time period, 564 randomly selected population controls, frequency-matched to the cases according to three 15-year age groups, were also interviewed. Continuous unconditional logistic regression methods were used for analysis. It was found that childbearing and use of oral contraceptives were associated with significant decreasing trends in risk of ovarian cancer; the respective odds ratios were 0.78 for each full-term pregnancy (p < 10(-8)) and 0.92 for each year of use (p < 10(-6)). Hysterectomy was also associated with reduced risk, even after more than 20 years. Among parous women, infertility did not appear to affect risk; for nulliparous women, some evidence of increased risk was present, although fertility problems were reported by only a small fraction of nulliparae. It is suggested that the relatively lower parity of cases as compared with controls may be due to voluntary choices for having fewer children.

Entities:  

Keywords:  Americas; Biology; Canada; Cancer; Case Control Studies; Contraception; Contraceptive Methods--beneficial effects; Demographic Factors; Developed Countries; Diseases; Family Planning; Fertility; Fertility Measurements; Gynecologic Surgery; Hysterectomy--beneficial effects; Infertility; Neoplasms; North America; Northern America; Oral Contraceptives--beneficial effects; Ovarian Cancer; Parity; Population; Population Dynamics; Pregnancy--beneficial effects; Reproduction; Retrospective Studies; Risk Factors; Studies; Surgery; Technical Report; Treatment; Urogenital Surgery

Mesh:

Year:  1994        PMID: 7942759     DOI: 10.1093/oxfordjournals.aje.a117296

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  48 in total

Review 1.  Modern trends into the epidemiology and screening of ovarian cancer. Genetic substrate of the sporadic form.

Authors:  Maria Koutsaki; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2011-12-09       Impact factor: 3.201

2.  Cancer in women after assisted reproductive technology.

Authors:  Barbara Luke; Morton B Brown; Logan G Spector; Stacey A Missmer; Richard E Leach; Melanie Williams; Lori Koch; Yolanda Smith; Judy E Stern; G David Ball; Maria J Schymura
Journal:  Fertil Steril       Date:  2015-08-10       Impact factor: 7.329

Review 3.  Role of p53 and Rb in ovarian cancer.

Authors:  David C Corney; Andrea Flesken-Nikitin; Jinhyang Choi; Alexander Yu Nikitin
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

4.  Hormonal risk factors for ovarian cancer in the Albanian case-control study.

Authors:  Edlira Pajenga; Tefta Rexha; Silva Çeliku; Gazmend Bejtja; Mimoza Pisha
Journal:  Bosn J Basic Med Sci       Date:  2013-05       Impact factor: 3.363

5.  Birth spacing and maternal risk of invasive epithelial ovarian cancer in a Swedish nationwide cohort.

Authors:  Inkyung Baik; Mats Lambe; Qin Liu; Lucy Chie; Sven Cnattingius; Lorelei A Mucci; Tomas Riman; Anders Ekbom; Hans-Olov Adami; Chung-Cheng Hsieh
Journal:  Cancer Causes Control       Date:  2008-05-29       Impact factor: 2.506

Review 6.  Use of fertility drugs and risk of ovarian cancer.

Authors:  Brenda Diergaarde; Michelle L Kurta
Journal:  Curr Opin Obstet Gynecol       Date:  2014-06       Impact factor: 1.927

7.  Reproductive factors and incidence of epithelial ovarian cancer: a Norwegian prospective study.

Authors:  G Albrektsen; I Heuch; G Kvåle
Journal:  Cancer Causes Control       Date:  1996-07       Impact factor: 2.506

8.  Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studies.

Authors:  Francesmary Modugno; Zhuxuan Fu; Susan J Jordan; Aocs Group; Jenny Chang-Claude; Renée T Fortner; Marc T Goodman; Kirsten B Moysich; Joellen M Schildkraut; Andrew Berchuck; Elisa V Bandera; Bo Qin; Rebecca Sutphen; John R McLaughlin; Usha Menon; Susan J Ramus; Simon A Gayther; Aleksandra Gentry-Maharaj; Chloe Karpinskyj; Celeste L Pearce; Anna H Wu; Harvey A Risch; Penelope M Webb
Journal:  Eur J Epidemiol       Date:  2020-09-21       Impact factor: 8.082

Review 9.  Current understanding of risk factors for ovarian cancer.

Authors:  Thanasak Sueblinvong; Michael E Carney
Journal:  Curr Treat Options Oncol       Date:  2009-07-15

Review 10.  Perineal talc use and ovarian cancer: a critical review.

Authors:  Joshua E Muscat; Michael S Huncharek
Journal:  Eur J Cancer Prev       Date:  2008-04       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.